AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1
slide-2
slide-3

Metglenide-G1 Tablet PR

Prescription Icon
Prescription Required

Marketer

German Remedies

Salt Composition

Glimepiride (1mg) + Metformin (500mg)

Overview Metglenide-G1 Tablet PR

Glimepiride-Metformin tablets are antidiabetic medications combining two drugs to manage type 2 diabetes in adults. These tablets help regulate blood sugar. Always take them with food, consistently at the same time daily for optimal effect. Dosage is determined by your physician and may adjust based on blood glucose monitoring. Continued use is crucial, even with controlled blood sugar; abrupt cessation can elevate glucose, potentially leading to kidney complications, vision loss, neuropathy, and limb amputation. This medication complements a comprehensive diabetes management plan encompassing diet, exercise, and weight management as directed by your doctor. Lifestyle significantly impacts diabetes control. Hypoglycemia (low blood sugar) is a common side effect. Learn to identify symptoms like sweating, dizziness, headache, and tremors, and know how to treat them. Regular meals and carrying readily available glucose (e.g., sugary snacks or juice) are preventative measures. Alcohol consumption should be minimized due to its hypoglycemic risk. Other possible side effects include altered taste, nausea, diarrhea, abdominal pain, headache, and upper respiratory infections. Weight gain may occur. This medication is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe kidney or liver impairment. Individuals with a history of heart disease should inform their physician before use. Pregnant or breastfeeding individuals require medical consultation prior to use. Regular blood glucose checks are necessary, and your doctor may order blood tests to monitor blood cell counts and liver function.

Uses of Metglenide-G1 Tablet PR

Managing type 2 diabetes

Major Benefits of Metglenide-G1 Tablet PR:

Follow your doctor's instructions or consult the product label for usage guidelines. Administer Metglenide-G1 Tablet PR with meals.

Common Side effects of Metglenide-G1 Tablet PR:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Metglenide-G1 Tablet PR:

Follow your doctor's instructions or the product label for proper administration. Take Metglenide-G1 Tablet PR with meals.

How Metglenide-G1 Tablet PR works:

Metformin and glimepiride, combined in Metglenide-G1 Tablet PR, offer a dual approach to diabetes management. Glimepiride, a sulfonylurea, stimulates the pancreas to release more insulin, thus reducing blood sugar levels. Metformin, a biguanide, acts through a three-pronged mechanism: decreasing liver glucose production, slowing intestinal glucose absorption, and enhancing insulin responsiveness.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Concurrent alcohol use with Metglenide-G1 Tablet PR is inadvisable.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Metglenide-G1 Tablet PR during pregnancy may pose risks. While human research is scant, animal studies indicate potential harm to a developing fetus. A physician will assess the advantages against possible risks prior to prescribing. Patient consultation with their doctor is advised.

Breast feedingBreast feedingUNSAFE

Breastfeeding mothers should not take Metglenide-G1 Tablet PR. Evidence indicates potential infant harm from this medication.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

Patients with kidney impairment should use Metglenide-G1 Tablet PR cautiously, potentially requiring dosage modification. Severe kidney disease contraindicates its use. Consult your physician. Regular monitoring of kidney function is recommended during treatment.

LiverLiverCAUTION

Individuals with liver impairment should exercise caution when using Metglenide-G1 Tablet PR. Dosage modification may be necessary. Physician consultation is advised. A low starting dose of Metglenide-G1 Tablet PR is typically recommended for those with mild to moderate liver disease; its use is contraindicated in patients with severe hepatic dysfunction.

What if you forget to take Metglenide-G1 Tablet PR :

Should you forget a Metglenide-G1 Tablet PR dose, administer it immediately if feasible. Otherwise, near the time for your next scheduled dose, omit the missed dose and resume your normal medication routine. Never take a double dose.

Facts to Know About Metglenide-G1 Tablet PR

LabelValue
Developing Habits No.
Treatment Category Diabetes Medication

FAQs on Metglenide-G1 Tablet PR

Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication and keep it out of reach of children, pets, and others.
Metglenide-G1 Tablet PR can cause lactic acidosis, a serious medical emergency characterized by excessive blood lactic acid (also known as MALA, or Metformin-associated lactic acidosis). This rare but potentially harmful side effect is more likely in patients with kidney disease, the elderly, or those who consume large amounts of alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these, discontinue Metglenide-G1 Tablet PR and seek immediate medical attention.
Metglenide-G1 Tablet PR combines glimepiride and metformin to manage type 2 diabetes mellitus (DM) in adults. This combination therapy improves blood glucose control when used with diet and exercise. Glimepiride stimulates insulin release from the pancreas, while metformin reduces liver glucose production and enhances insulin sensitivity. It's not suitable for treating type 1 DM.
Metglenide-G1 Tablet PR may cause common side effects such as hypoglycemia, altered taste, nausea, stomach pain, diarrhea, and headache. Rare but serious side effects include lactic acidosis. Prolonged use can also result in vitamin B12 deficiency.
Prolonged Metglenide-G1 Tablet PR use can induce vitamin B12 deficiency by impairing its stomach absorption. This deficiency, if left untreated, may lead to anemia, neurological issues such as tingling, numbness in extremities, weakness, urinary dysfunction, cognitive changes, and ataxia. To mitigate these risks, annual supplemental vitamin B12 is recommended by some researchers.
Metglenide-G1 Tablet PR can cause hypoglycemia (low blood sugar). Symptoms include nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, and anxiety or shakiness. This risk increases if you skip meals, drink alcohol, overexert yourself, or take other diabetes medications. Regular blood sugar monitoring is crucial. Always carry a fast-acting sugar source, such as glucose tablets, honey, or fruit juice.
Combining Metglenide-G1 Tablet PR and alcohol is unsafe. Alcohol can exacerbate Metglenide-G1's blood sugar-lowering effects, potentially causing hypoglycemia and increasing the risk of lactic acidosis.
Metglenide-G1 Tablet PR
64
MRP 78
17% off